AAAAAA
Results:
1-13
|
Results: 13
Authors:
BROUWENSTIJN N
HOOGSTRATEN C
VERDEGAAL EME
VANDERSPEK CW
DECKERS JG
MULDER S
OSANTO S
SCHRIER PI
Citation: N. Brouwenstijn et al., DEFINITION OF UNIQUE AND SHARED T-CELL DEFINED TUMOR-ANTIGENS IN HUMAN RENAL-CELL CARCINOMA, Journal of immunotherapy, 21(6), 1998, pp. 427-434
Authors:
VANELSAS A
AARNOUDSE C
VANDERMINNE CE
VANDERSPEK CW
BROUWENSTIJN N
OSANTO S
SCHRIER PI
Citation: A. Vanelsas et al., TRANSFECTION OF IL-2 AUGMENTS CTL RESPONSE TO HUMAN-MELANOMA CELLS IN-VITRO - IMMUNOLOGICAL CHARACTERIZATION OF A MELANOMA VACCINE, Journal of immunotherapy with emphasis on tumor immunology, 20(5), 1997, pp. 343-353
Authors:
OSANTO S
Citation: S. Osanto, TOXICITY, CLINICAL EFFECTS AND CTLP-FREQUENCIES IN MELANOMA PATIENTS IMMUNIZED WITH IL-2 GENE MODIFIED MELANOMA-CELLS, Cancer gene therapy, 4(5), 1997, pp. 333-333
Authors:
ABDELWAHAB Z
DAR M
OSANTO S
FONG T
VERVAERT CE
HESTER D
JOLLY D
SEIGLER HF
Citation: Z. Abdelwahab et al., ERADICATION OF MELANOMA PULMONARY METASTASES BY IMMUNOTHERAPY WITH TUMOR-CELLS ENGINEERED TO SECRETE INTERLEUKIN-2 OR GAMMA-INTERFERON, Cancer gene therapy, 4(1), 1997, pp. 33-41
Authors:
WEIJL NI
CLETON FJ
OSANTO S
Citation: Ni. Weijl et al., FREE-RADICALS AND ANTIOXIDANTS IN CHEMOTHERAPY-INDUCED TOXICITY, Cancer treatment reviews, 23(4), 1997, pp. 209-240
Authors:
BROUWENSTIJN N
GAUGLER B
KRUSE KM
VANDERSPEK CW
MULDER A
OSANTO S
VANDENEYNDE BJ
SCHRIER PI
Citation: N. Brouwenstijn et al., RENAL-CELL CARCINOMA-SPECIFIC LYSIS BY CYTOTOXIC T-LYMPHOCYTE CLONES ISOLATED FROM PERIPHERAL-BLOOD LYMPHOCYTES AND TUMOR-INFILTRATING LYMPHOCYTES, International journal of cancer, 68(2), 1996, pp. 177-182
Authors:
SCHRIER PI
BROUWENSTIJN N
WEIJL N
FLEUREN GJ
MELIEF CJM
OSANTO S
Citation: Pi. Schrier et al., GENE-THERAPY OF MELANOMA PATIENTS WITH IL-2 TRANSFECTED MELANOMA-CELLS, Journal of cellular biochemistry, 1995, pp. 176-176
Authors:
ABDELWAHAB ZA
OSANTO S
DARROW TL
BARBER JR
VERVAERT CE
GANGAVALLI R
MCCALLISTER TJ
SEIGLER HF
Citation: Za. Abdelwahab et al., TRANSDUCTION OF HUMAN-MELANOMA CELLS WITH THE GAMMA-INTERFERON GENE ENHANCES CELLULAR-IMMUNITY, Cancer gene therapy, 1(3), 1994, pp. 171-179
Authors:
TATES AD
VANDAM FJ
NATARAJAN AT
ZWINDERMAN AH
OSANTO S
Citation: Ad. Tates et al., FREQUENCIES OF HPRT MUTANTS AND MICRONUCLEI IN LYMPHOCYTES OF CANCER-PATIENTS UNDER CHEMOTHERAPY - A PROSPECTIVE-STUDY, MUTATION RESEARCH, 307(1), 1994, pp. 293-306
Authors:
ABDELWAHAB Z
LI WP
OSANTO S
DARROW TL
HESSLING J
VERVAERT CE
BURRASCANO M
BARBER J
SEIGLER HF
Citation: Z. Abdelwahab et al., TRANSDUCTION OF HUMAN-MELANOMA CELLS WITH INTERLEUKIN-2 GENE REDUCES TUMORIGENICITY AND ENHANCES HOST ANTITUMOR IMMUNITY - A NUDE-MOUSE MODEL, Cellular immunology, 159(1), 1994, pp. 26-39
Authors:
OSANTO S
BROUWENSTYN N
VAESSEN N
FIGDOR CG
MELIEF CJM
SCHRIER PI
Citation: S. Osanto et al., IMMUNIZATION WITH INTERLEUKIN-2 TRANSFECTED MELANOMA-CELLS - A PHASE-I-II STUDY IN PATIENTS WITH METASTATIC MELANOMA, Human gene therapy, 4(3), 1993, pp. 323-330
Authors:
WEIJL NI
VANDERHARST D
BRAND A
KOOY Y
VANLUXEMBURG S
SCHRODER J
LENTJES E
VANROOD JJ
CLETON FJ
OSANTO S
Citation: Ni. Weijl et al., HYPOTHYROIDISM DURING IMMUNOTHERAPY WITH INTERLEUKIN-2 IS ASSOCIATED WITH ANTITHYROID ANTIBODIES AND RESPONSE TO TREATMENT, Journal of clinical oncology, 11(7), 1993, pp. 1376-1383
Authors:
OSANTO S
BUKMAN A
VANHOEK F
STERK PJ
DELAAT JAPM
HERMANS J
Citation: S. Osanto et al., LONG-TERM EFFECTS OF CHEMOTHERAPY IN PATIENTS WITH TESTICULAR CANCER, Journal of clinical oncology, 10(4), 1992, pp. 574-579
Risultati:
1-13
|